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Hyperbaric Oxygen, Laser 
Photodynamic Therapies and 
Mitochondrial Support




In the multiple therapies which may synergize HBOT the use of 
Laser (photodynamic) therapy is not well known in North 
America. 
In this session Dr. Anderson will outline his use of HBOT-Laser 
and IV Therapies to enhance mitochondrial function and 
healing. 
Mechanisms of action and common complementary 
modalities will be discussed.
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Photodynamic Therapies
Laser
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PDT - Laser
• Stem cell activation
• Immunologic stimulation
• Mitochondrial support
• Direct cancer therapy
• And: Synergy with HBOT
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References / Links for those papers
• Stem Cell Support Part-1
https://www.academia.edu/36317398/Stem_Cell_Support_Part-
1_Integrative_Pain_Management
• Stem Cell Support Part-2
https://www.academia.edu/36317439/Stem_Cell_Support_Part-
2_Integrative_Pain_Management
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Given the MOA of PDT it appears that HBOT 
and PDT are synergistic:
Any Data?
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PMID: 10691271 (2000) +
BACKGROUND AND STUDY AIMS: Experimental studies have shown that the cytotoxicity of 
porphyrins and related substances is mediated mainly by singlet oxygen and that hypoxic cells are 
less affected by porphyrins and light. In a clinical pilot study we assessed the use of photodynamic 
therapy (PDT) under hyperbaric oxygen (HBO), compared with PDT under normobaric conditions, in 
patients with advanced esophageal carcinoma.
PATIENTS AND METHODS: …Of the patients, 14 (12 with stage III cancers, and two with stage IV 
cancers) were treated by PDT alone, and 17 patients (15 with stage III cancers, and two with stage 
IV cancers) received PDT under HBO at a level of 2 absolute atmospheric pressures (ATA). 
Transcutaneous PO2 levels of 500-750 mm Hg under HBO, compared with transcutaneous PO2 
levels of 60-75 mm Hg under normobaric conditions, were measured.
RESULTS: …The 12-month survival rate was 28.6% for the PDT group and 41.2% for the PDT/HBO 
group. Logrank test showed a difference in survival in favor of the PDT/HBO group (P = 0.059). No 
major treatment-related complication occurred, and the 30-day mortality rate was 0%.
CONCLUSIONS: Combined PDT/HBO represents a new approach in the treatment of esophageal 
cancer which, in this pilot study, appears to have enhanced the efficiency of PDT.
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https://doi.org/10.1002/(SICI)1096-9101(2000)26:3<308::AID-LSM9>3.0.CO;2-B 
(2000) +
Background and Objective: The photochemical reaction of photodynamic therapy 
(PDT) depends on the presence of molecular oxygen. Because of anoxic regions in 
tumor tissue and vascular shutdown during PDT, the efficiency is limited. 
Therefore, the use of hyperbaric oxygen, which increases the oxygen in tumor 
tissue, as well as the amount of singlet oxygen, may enhance the efficiency of PDT.
Study Design/Materials and Methods: Twenty‐three patients were treated by PDT 
alone and 29 patients received PDT under hyperbaric oxygen at a level of two 
absolute atmospheric pressures.
Results: …The mean overall survival was 11.3 months. The mean survival time for 
the PDT group was 8.7 months and for the PDT/HBO group 13.8 months (P = 
0.021).
Conclusion: According to this pilot study, combined PDT/HBO represents a new 
approach in the treatment of esophageal and cardia cancer, which appears to have 
enhanced the efficiency of PDT. 
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https://doi.org/10.1002/lsm.1067 
(2001) +
Background and Objective: Photodynamic tumor therapy (PDT) is based upon a 
photochemical reaction that is limited by the availability of molecular oxygen in the target 
tissue. The use of hyperbaric oxygenation (HBO) increases the amount of oxygen available 
for the process may thereby enhance the efficacy of PDT. We investigated the acute effects 
on tumor stenosis after combined PDT/HBO.
Patients and Methods: Thirty patients (22 males, 8 females, mean age: 68.8 years; range: 
44–78 years) with inoperable non‐small cell bronchogenic carcinoma and endobronchial 
stenosis were studied prospectively. 
Results: …A significant reduction of tumor stenosis (P < 0.05) and an improvement of the 
Karnofsky performance status (P < 0.05) were documented 1 and 4 weeks after 
PDT/HBO. No therapy related complications were observed.
Conclusions: Although the small number of patients does not allow to draw definitive 
conclusions to be drawn, the results suggests that combined PDT/HBO represents a new, 
safe, and technically feasible approach. It enables efficient and rapid reduction of the 
endoluminal tumor load and helps conditioning the patient for further treatment 
procedures.
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https://doi.org/10.1016/S1572-1000(04)00009-2 
(2004) +
Introduction: … The aim of this study was to evaluate the additional effect of intraoperative 
photodynamic therapy (PDT) under hyperbaric oxygenation (HBO) if compared to 
decortication alone. 
Patients and methods: From January 1993 to August 2003, decortication was done in 34 
patients (28 males, 6 females; mean age: 65 years) suffering from advanced malignant 
pleural mesothelioma. Twenty-two patients received additional intraoperative PDT under 
HBO. 
Results: At 6-month follow-up the Karnofsky performance status showed no significant 
difference (P≥0.05) between both groups. CT scans documented focal regrowth of the 
tumour after 6 months in 10/12 cases of the non-PDT group. However, in the PDT group 
tumour regrowth was detected in only 9/22 cases at 6-month follow-up. 
Conclusion: Although the study includes only a small number of patients, it indicates that 
additional PDT/HBO represents a safe and technically feasible approach in the palliative 
setting of advanced malignant mesothelioma of the pleura.
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Other Data?
• (2016) +     A. Neves, A. Abrantes, A. Pires, R. Teixo, M.F. Botelho. 
Hyperbaric oxygen therapy combined with photodynamic therapy as 
a new therapeutic approach against retinoblastoma. DOI: 
https://doi.org/10.1016/S0959-8049(16)61507-1
• (2016) Excellent review with extensive immunology data on PDT: 
Photodynamic Therapy of Non–Small Cell Lung Cancer. Narrative 
Review and Future Directions. https://doi.org/10.1513/Annals 
ATS.201509-650FR.PMID26646726
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Synergizing Upconversion Nanophotosensitizers with Hyperbaric Oxygen to Remodel the Extracellular 
Matrix for Enhanced Photodynamic Cancer Therapy. ACS Appl. Mater. Interfaces  10, 27, 22985-22996 
(2018) +
“With HBO, photodynamic process can generate abundant ROS in the 
intrinsically hypoxic tumor. It is revealed for the first time that HBO-
assisted PDT decomposes collagen in the extracellular matrix of tumor 
and thus facilitates the diffusion of oxygen and penetration of UNPSs 
into the deeper area of tumor. Such a synergic effect eventually results 
in a significantly enhanced therapeutic efficacy at a low laser power 
density as compared with that using UNPSs alone. In view of its good 
biosafety, the HBO-assisted and UNPSs-mediated PDT provides new 
possibilities for treatment of solid tumors.”
(c) PS Anderson www.ConsultDrA.com 2018 21
(c) PS Anderson www.ConsultDrA.com 2018 22
Photosensitizers:
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Poly-MVA
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Poly-MVA
aka. Lipoic Acid Mineral Complex (LAMC):
Known as the proprietary formula “Poly MVA” in North 
America, LAMC has shown to be helpful in cell repair, 
mitochondrial repair and radioprotection [18-21].  
The author has found that low IV doses (5-15 mL) combined 
with low oral doses (5-10 mL BID) improve energy via 
mitochondrial support.
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Poly-MVA Reference
LAMC (PolyMVA) – Anderson
https://www.academia.edu/20316600/Lipoic_Acid_Mineral_Complex_
PolyMVA_Monograph
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Poly-MVA as a support
AND
Photosensitizer
(c) PS Anderson www.ConsultDrA.com 2018 28
Poly-MVA Full Strength
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Poly-MVA 50% Dilution
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Poly-Plus (with retinoid)
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Silver Nanoparticles 
(we use 23 ppm Argentyn)
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Thiamine (B-1)
DOI: 10.5897/AJPP2016.4542
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Riboflavin (B-2)
doi:10.1167/iovs.12-9537
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Niacin (B-3)
https://www.propharmagroup.com/blog/impact-wavelength-accuracy-and-precision-spectrophotometric-measurements/
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NAD-NADH from Nicotinamide (B-3)
https://socratic.org/questions/how-does-a-spectrophotometer-work
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B-12
http://www.pnas.org/content/pnas/103/15/5694/F3.large.jpg
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Summary:
•PDT Laser is an incredibly potent therapy
•PDT – Laser has many potential applications in 
chronic, acute and cancerous states.
•PDT + HBOT has been shown to be synergistic
•Multiple photosensitizers beyond the “known agents” 
are available and potentially synergistic.
(c) PS Anderson www.ConsultDrA.com 2018 42






• AAMP Portland: Chronic Infectious Illness and Advanced Integrative 
Medicine. September 28 - 30, 2018
www.aampportland.com
• Dr. A Web:
www.ConsultDrA.com
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